Search Results - "Gillham, Charles M"

A Randomized Trial (Irish Clinical Oncology Research Group 97-01) Comparing Short Versus Protracted Neoadjuvant Hormonal Therapy Before Radiotherapy for Localized Prostate Cancer by Armstrong, John G., F.F.R.R.C.S.I, Gillham, Charles M., F.R.C.R, Dunne, Mary T., M.Sc, Fitzpatrick, David A., F.F.R.R.C.S.I, Finn, Marie A, Cannon, Mairín E., Ph.D, Taylor, Judy C., B.Sc, O'Shea, Carmel M., B.N.S, Buckney, Steven J, Thirion, Pierre G., F.F.R.R.C.S.I

“…Purpose To examine the long-term outcomes of a randomized trial comparing short (4 months; Arm 1) and long (8 months; Arm 2) neoadjuvant hormonal therapy…”
Get full text

Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death by Mc Entee, Philip D, Shokuhi, Poorya, Rogers, Ailin C, Mehigan, Brian J, McCormick, Paul H, Gillham, Charles M, Kennedy, M John, Gallagher, David J, Ryan, Ciara E, Muldoon, Cian B, Larkin, John O

“…Colorectal cancer (CRC) outcomes vary depending on tumour biology, with several features used to predict disease behaviour. Extramural venous invasion (EMVI)…”
Get full text

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation by Gillham, Charles M, Reynolds, John, Hollywood, Donal

“…A complete pathological response to neo-adjuvant chemo-radiation for oesophageal cancer is associated with favourable survival. However, such a benefit is seen…”
Get full text

Correspondence: prostatic sarcoma after treatment for rectal cancer by Aherne, Noel J, Gillham, Charles M

Get full text

Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer by Maher, Stephen G, Gillham, Charles M, Duggan, Shane P, Smyth, Paul C, Miller, Nicola, Muldoon, Cian, O'Byrne, Kenneth J, Sheils, Orla M, Hollywood, Donal, Reynolds, John V

“…This study explored gene expression differences in predicting response to chemoradiotherapy in esophageal cancer. A major pathological response to neoadjuvant…”
Get full text

The curative management of synchronous rectal and prostate cancer by Lavan, Naomi A, Kavanagh, Dara O, Martin, Joseph, Small, Cormac, Joyce, Myles R, Faul, Clare M, Kelly, Paul J, O'Riordain, Michael, Gillham, Charles M, Armstrong, John G, Salib, Osama, McNamara, Deborah A, McVey, Gerard, O'Neill, Brian D P

“…Neoadjuvant "long-course" chemoradiation is considered a standard of care in locally advanced rectal cancer. In addition to prostatectomy, external beam…”
Get full text

Chemotherapy for Lung Cancer by Locke, Imogen, Gillham, Charles M

“…To the Editor: Schiller and colleagues (Jan. 10 issue) 1 report equivalent overall survival and response rates for four third-generation chemotherapy regimens…”
Get full text

Gene Expression Analysis of Diagnostic Biopsies Predicts Pathological Response to Neoadjuvant Chemoradiotherapy of Esophageal Cancer. Discussion by MAHER, Stephen G, GILLHAM, Charles M, BONAVINA, L, O'CONNELL, P. R, SENNINGER, N, DUGGAN, Shane P, SMYTH, Paul C, MILLER, Nicola, MULDOON, Cian, O'BYRNE, Kenneth J, SHEILS, Orla M, HOLLYWOOD, Donal, REYNOLDS, John V

Get full text